NextCure, Inc. (NXTC)
NASDAQ·Healthcare·Biotechnology
$2.13
+8.93%
Mkt Cap $33.52M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+604.2%
Consensus $15.00 vs current $2.13
NASDAQ·Healthcare·Biotechnology
$2.13
+8.93%
Mkt Cap $33.52M
No recent rating data.
Price Target (3 analysts)
$15.00
Range $15.00 – $15.00
+604.2%
Consensus $15.00 vs current $2.13